X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (237) 237
humans (232) 232
hypertension, pulmonary - drug therapy (178) 178
pulmonary hypertension (156) 156
pulmonary arterial hypertension (110) 110
administration, oral (103) 103
respiratory system (101) 101
male (99) 99
female (98) 98
treatment outcome (95) 95
oral treprostinil (92) 92
oral sildenafil (86) 86
double-blind (84) 84
cardiac & cardiovascular systems (82) 82
prostacyclin (81) 81
5 inhibitor therapy (78) 78
pharmacology & pharmacy (77) 77
antihypertensive agents - therapeutic use (75) 75
hypertension, pulmonary - physiopathology (73) 73
inhaled iloprost (73) 73
adult (72) 72
antihypertensive agents - administration & dosage (71) 71
middle aged (70) 70
epoprostenol - analogs & derivatives (67) 67
hypertension (67) 67
bosentan (66) 66
endothelin receptor antagonist (64) 64
sildenafil (63) 63
treprostinil (63) 63
sildenafil citrate (62) 62
therapy (60) 60
epoprostenol - therapeutic use (58) 58
drug therapy (57) 57
drug therapy, combination (55) 55
survival (55) 55
arterial-hypertension (53) 53
care and treatment (52) 52
vasodilator agents - therapeutic use (52) 52
randomized controlled-trial (51) 51
abridged index medicus (49) 49
continuous intravenous epoprostenol (49) 49
epoprostenol - administration & dosage (48) 48
placebo-controlled trial (43) 43
epoprostenol (42) 42
vasodilator agents - administration & dosage (42) 42
piperazines - therapeutic use (41) 41
prostacyclin analog (38) 38
hypertension, pulmonary - diagnosis (37) 37
inhaled nitric-oxide (37) 37
aged (35) 35
combination therapy (35) 35
hypertension, pulmonary - etiology (35) 35
antihypertensive agents - adverse effects (34) 34
mortality (31) 31
iloprost (30) 30
medicine, general & internal (30) 30
administration, inhalation (29) 29
endothelin (29) 29
endothelin receptor antagonists (29) 29
endothelin-receptor antagonist (29) 29
pharmacokinetics (29) 29
diagnosis (28) 28
efficacy (28) 28
pulmonary arteries (28) 28
research (28) 28
sulfonamides - therapeutic use (28) 28
adolescent (27) 27
intravenous epoprostenol (27) 27
medicine & public health (27) 27
nitric oxide (26) 26
purines - therapeutic use (26) 26
critical care medicine (25) 25
hypertension, pulmonary - mortality (25) 25
long-term treatment (25) 25
randomized controlled trials as topic (25) 25
sulfones - therapeutic use (25) 25
young adult (25) 25
clinical trials (24) 24
drug administration schedule (24) 24
hypertension, pulmonary - therapy (24) 24
piperazines - administration & dosage (24) 24
phosphodiesterase 5 inhibitors - therapeutic use (23) 23
antihypertensive agents - pharmacokinetics (22) 22
child (22) 22
controlled-trial (22) 22
dose-response relationship, drug (22) 22
familial primary pulmonary hypertension (22) 22
health aspects (22) 22
patients (22) 22
phosphodiesterase inhibitors - therapeutic use (22) 22
purines (22) 22
sulfones (22) 22
time factors (22) 22
analysis (21) 21
animals (21) 21
epoprostenol - adverse effects (21) 21
internal medicine (21) 21
review (21) 21
calcium-channel blockers (20) 20
dosage and administration (20) 20
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, ISSN 0009-7322, 02/2013, Volume 127, Issue 5, pp. 624 - 633
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2010, Volume 55, Issue 18, pp. 1915 - 1922
Journal Article
Chest, ISSN 0012-3692, 2013, Volume 144, Issue 3, pp. 952 - 958
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2011, Volume 30, Issue 12, pp. 1327 - 1333
Journal Article
Chest, ISSN 0012-3692, 2012, Volume 142, Issue 6, pp. 1383 - 1390
Journal Article
Pulmonary Pharmacology & Therapeutics, ISSN 1094-5539, 04/2018, Volume 49, pp. 104 - 111
INS1009 is a long acting pulmonary vasodilator prodrug of treprostinil (TRE) that is formulated in a lipid nanoparticle for inhaled delivery by nebulization.... 
Pulmonary vasodilation | Treprostinil | Rats | Local lung effect | Hexadecyl-treprostinil prodrug | Dogs | VASORELAXATION | AEROSOL | INHIBITION | RESPIRATORY SYSTEM | PROSTACYCLIN ANALOG | NITRIC-OXIDE | PHARMACOLOGY & PHARMACY | ORAL TREPROSTINIL | RECEPTORS | HYPERTENSION | PROSTAGLANDIN E-2 | VASOCONSTRICTION | Index Medicus
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 2016, Volume 36, Issue 2, pp. 193 - 201
Journal Article
Journal Article
Journal of Pharmacy Practice, ISSN 0897-1900, 2018, pp. 897190018764585 - 897190018764585
Treprostinil diolamine is the first oral dosage preparation of a prostacyclin analogue for use in treatment naive pulmonary arterial hypertension (PAH). This... 
prostacyclin | oral treprostinil | pulmonary hypertension | transition | switch
Journal Article
Journal of Heart and Lung Transplantation, ISSN 1053-2498, 07/2019, Volume 38, Issue 7, pp. 748 - 756
Journal Article
Journal Article
Journal Article
Journal Article
Pulmonary Circulation, ISSN 2045-8932, 7/2018, Volume 8, Issue 2, pp. 2045894018770654 - 2045894018770654
Pharmacokinetic studies with oral treprostinil demonstrate that three times daily (TID) dosing reduces peak-to-trough plasma trepostinil fluctuations compared... 
real-world use | treprostinil | dosing | oral treprostinil | 5 INHIBITOR THERAPY | CARDIAC & CARDIOVASCULAR SYSTEMS | PHARMACOKINETICS | PULMONARY ARTERIAL-HYPERTENSION | RESPIRATORY SYSTEM | RANDOMIZED CONTROLLED-TRIAL | ENDOTHELIN RECEPTOR ANTAGONIST
Journal Article